Cite

HARVARD Citation

    Hyman, D. et al. (n.d.). Dose- and regimen-finding phase I study of NVP-HDM201 in patients (pts) with TP53 wild-type (wt) advanced tumors. European journal of cancer. pp. S128-S129. [Online]. 
  
Back to record